BamSEC and AlphaSense Join Forces
Learn More

Outset Medical Inc.

NASDAQ: OM    
Share price (1/7/26): $4.34    
Market cap (1/7/26): $78.8 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 10-Q 4 pages Material contract
12/34/56
EX-10.2
from 10-Q 14 pages Outset Medical, Inc. Employee Stock Purchase Plan
12/34/56
EX-10.1
from 10-Q 20 pages Outset Medical, Inc. 2020 Equity Incentive Plan Adopted by the Board of Directors: September 2, 2020 Approved by the Stockholders: September 7, 2020 Amended and Restated, Effective March 20, 2025 Approved by the Stockholders: June 2, 2025 (In Respect of Amendment 2025-1) Amended and Restated, Effective August 6, 2025 Termination Date: September 2, 2030 I. Introduction
12/34/56
EX-10.2
from 10-Q 14 pages Outset Medical, Inc. Employee Stock Purchase Plan Adopted by the Board of Directors: September 2, 2020 Approved by the Stockholders: September 7, 2020 Termination Date: September 2, 2030 (Amended and Restated, Effective April 9, 2025) 1
12/34/56
EX-10.1
from 10-Q 20 pages 2020 Equity Incentive Plan Adopted by the Board of Directors: September 2, 2020 Approved by the Stockholders: September 7, 2020 Amended and Restated, Effective March 20, 2025 Termination Date: September 2, 2030 I. Introduction
12/34/56
EX-10.3
from 8-K 19 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 41 pages Securities Purchase Agreement by and Among Outset Medical, Inc., and the Purchasers as Set Forth Herein January 3, 2025
12/34/56
EX-10.1
from 8-K 43 pages Securities Purchase Agreement by and Among Outset Medical, Inc., and the Purchasers as Set Forth Herein January 3, 2025
12/34/56
EX-10.2
from 10-Q 2 pages Tacna Services, Inc. Manufacturing Service Agreement Client: Outset Medical Annex "A" (Service Fee Schedule) Effective February 12, 2024
12/34/56
EX-10.12
from 10-K 10 pages Outset Medical, Inc. Amended and Restated Change in Control and Severance Agreement
12/34/56
EX-10.11
from 10-K 10 pages Outset Medical, Inc. Amended and Restated Change in Control and Severance Agreement
12/34/56
EX-10.4
from 10-K 16 pages Outset Medical, Inc. 2020 Equity Incentive Plan Adopted by the Board of Directors: September 2, 2020 Approved by the Stockholders: September 7, 2020 Amended and Restated : January 1, 2024 Termination Date: September 2, 2030 I. Introduction
12/34/56
EX-10.3
from 10-Q 12 pages Outset Medical, Inc. Employee Stock Purchase Plan Adopted by the Board of Directors: September 2, 2020 Approved by the Stockholders: September 7, 2020 Termination Date: September 2, 2030 (Amended and Restated, Effective September 1, 2022) 1
12/34/56
EX-10.2
from 10-Q 70 pages Portions of This Exhibit Have Been Excluded Because It Is Both (I) Not Material and (II) the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential
12/34/56
EX-10.1
from 10-Q 63 pages Portions of This Exhibit Have Been Excluded Because It Is Both (I) Not Material and (II) the Type of Information That the Registrant Both Customarily and Actually Treats as Private and Confidential
12/34/56
EX-10.9
from 10-K 13 pages Outset Medical, Inc. Employee Stock Purchase Plan Adopted by the Board of Directors: September 2, 2020 Approved by the Stockholders: September 7, 2020 Termination Date: September 2, 2030 (Amended and Restated, Effective March 1, 2022) 1
12/34/56
EX-10.30
from 10-K 30 pages Background
12/34/56
EX-10.29
from 10-K 2 pages *Portions of This Exhibit Have Been Excluded Because It Both (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed
12/34/56
EX-10.8
from 10-K 8 pages Outset Medical, Inc. Performance Stock Unit Award Grant Notice
12/34/56
EX-10.7
from 10-K 8 pages Outset Medical, Inc. Restricted Stock Award Grant Notice
12/34/56